Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc. | 5.260% | 29.464% | 28.319% | -48.307% | -50.300% | -84.820% | - |
| Vical Inc. | 5.300% | - | - | - | - | - | - |
| Abeona Therapeutics Inc. | 5.530% | 10.053% | -2.804% | 10.697% | -11.677% | -88.055% | - |
| InVivo Therapeutics Holdings | 5.590% | -0.585% | 9.677% | -70.790% | -50.581% | -99.928% | -99.942% |
| Natera Inc | 5.640% | 0.990% | 12.707% | 122.707% | 80.531% | - | - |
| Personalis Inc | 5.940% | 11.497% | -9.953% | -40.721% | -35.192% | -92.094% | - |
| Seres Therapeutics Inc | 6.020% | 21.537% | -1.834% | -77.105% | -20.305% | -94.373% | - |
| Sangamo Therapeutics Inc. | 6.040% | 1.411% | 4.966% | -50.000% | -6.277% | -93.980% | -93.526% |
| Ocuphire Pharma Inc. | 6.180% | 4.712% | -7.514% | -57.333% | -42.755% | - | - |
| Exact Sciences | 6.210% | 0.891% | -27.401% | -47.201% | -38.895% | -52.339% | -55.290% |
| CEL-SCI Corp. | 6.430% | 2.115% | -24.149% | -51.708% | -55.078% | -94.319% | - |
| Radnet Inc. | 6.480% | 2.727% | 18.697% | 98.944% | 74.383% | - | - |
| Seaspine Holdings Corp | 6.670% | - | - | - | - | - | - |
| Cellectar BioSciences Inc. | 6.720% | 5.147% | -10.063% | 72.289% | 25.439% | -77.656% | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Capricor Therapeutics Inc | 7.130% | 2.896% | 8.998% | 26.005% | 19.106% | 67.610% | - |
| XBiotech Inc | 7.140% | 0.000% | -14.013% | 36.089% | 90.678% | -50.838% | 8.347% |
| Premier Inc. | 7.240% | - | - | - | - | - | - |
| Evolent Health Inc | 7.290% | -2.830% | -19.531% | -29.452% | -31.788% | - | - |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Akero Therapeutics Inc | 7.540% | 6.663% | 4.793% | -60.638% | -12.248% | - | - |
| Arch Therapeutics Inc | 8.430% | - | - | - | - | - | - |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |
| BioScrip Inc. | 9.810% | - | - | - | - | - | - |
| Cytokinetics Inc. | 10.760% | 13.739% | -17.213% | 42.655% | -33.987% | 190.230% | - |